Neddylation-the conjugation of the ubiquitin-like protein NEDD8 to its target proteins-is an essential biological process that critically regulates cell-cycle progression in eukaryotes including yeast and humans [1] [2] [3] [4] . Like ubiquitination, neddylation is achieved through a sequential enzymatic cascade involving an activating enzyme (E1), a conjugating enzyme (E2), and a ligase (E3) (Fig. 1a) . To date, one E1 enzyme (APPBP1-UBA3), two E2 enzymes (Ubc12, also known as Ube2M, and Ube2F), and many E3 ligases have been identified to act in neddylation [5] [6] [7] [8] (Fig. 1a) . Although numerous NEDD8 targets have been reported 9 , the biological functions of neddylation have primarily been characterized to date in the context of its main targets-the cullin proteins, key components of the ubiquitin E3 cullin-RING ligase family. Neddylation of cullin activates the E3 ligases for ubiquitination and promotes the degradation of their downstream targets, including key regulators of the cell cycle 10 .
a r t i c l e s
Neddylation-the conjugation of the ubiquitin-like protein NEDD8 to its target proteins-is an essential biological process that critically regulates cell-cycle progression in eukaryotes including yeast and humans [1] [2] [3] [4] . Like ubiquitination, neddylation is achieved through a sequential enzymatic cascade involving an activating enzyme (E1), a conjugating enzyme (E2), and a ligase (E3) (Fig. 1a) . To date, one E1 enzyme (APPBP1-UBA3), two E2 enzymes (Ubc12, also known as Ube2M, and Ube2F), and many E3 ligases have been identified to act in neddylation [5] [6] [7] [8] (Fig. 1a) . Although numerous NEDD8 targets have been reported 9 , the biological functions of neddylation have primarily been characterized to date in the context of its main targets-the cullin proteins, key components of the ubiquitin E3 cullin-RING ligase family. Neddylation of cullin activates the E3 ligases for ubiquitination and promotes the degradation of their downstream targets, including key regulators of the cell cycle 10 .
The initial interest in finding a connection between ubiquitination (or ubiquitin-like modifications) and GlyRS was based on molecular considerations. Ubiquitin and most ubiquitin-like-modifier proteins, including NEDD8, have a conserved C-terminal glycine that is used to activate, conjugate, and finally attach the modifiers to their targets 11 . Structurally, the glycine residue is located at the tip of a flexible 'tail' that protrudes from the central ubiquitin fold and provides accessibility 12 .
The well-known function of GlyRS is to catalyze the formation of glycyl-tRNA Gly as a substrate for ribosomal protein synthesis in a twostep reaction 13 : first, GlyRS activates glycine with ATP, thus generating Gly-AMP; second, the glycyl moiety is transferred from Gly-AMP to the 3′ end of tRNA Gly . Interestingly, this first-step reaction catalyzed by GlyRS is chemically equivalent to that catalyzed by E1 enzymes in the activation of ubiquitin and ubiquitin-like proteins. Moreover, our previous work has indicated that the specific amino acid-binding pocket of a tRNA synthetase, and its binding to a cognate amino acid residue on a protein, can be exploited to develop new functions 14 .
We set out to test whether human GlyRS interacts with ubiquitin or ubiquitin-like proteins such as NEDD8 and SUMO1 and found that GlyRS specifically binds NEDD8. Although we did not find an E1-like activity in GlyRS as initially speculated, we did find that GlyRS binds both E1 and E2 (Ubc12) enzymes functioning in neddylation. Moreover, when Ubc12 was conjugated with NEDD8, its affinity for GlyRS was substantially enhanced, thus suggesting that GlyRS may protect activated E2 before the E2 finds its correct downstream targets. Indeed, knockdown of GlyRS, but not knockdown of another tRNA synthetase, substantially decreased the level of activated Ubc12 and the level of cullin neddylation in human cells. Moreover, knockdown of GlyRS mimicked the effect of MLN4924, a specific inhibitor of neddylation E1, and caused cell-cycle arrest. Therefore, our study reveals a chaperone-like function of GlyRS that critically supports neddylation.
RESULTS

GlyRS specifically binds NEDD8 and enhances neddylation
Using purified recombinant proteins, we found that human GlyRS specifically bound NEDD8 but did not bind ubiquitin or SUMO1 (Fig. 1b) . We also tested two other human tRNA synthetases (SerRS and TrpRS) side by side and found that neither interacted with NEDD8, ubiquitin, or SUMO1 (Fig. 1b) . We further verified the GlyRS-NEDD8 interaction in HEK293 cells by coimmunoprecipitation (Fig. 1c) . By using truncated recombinant proteins, we mapped the interaction to the catalytic domain of GlyRS (Fig. 1d,e) . Hydrogen/deuterium exchange (HDX) analysis confirmed that the catalytic domain was the site of interaction with NEDD8 (Supplementary Fig. 1a) .
To test the effects of GlyRS on neddylation, first we ectopically expressed GlyRS in HEK293 cells. Overexpression of GlyRS (but not TrpRS) increased the amount of NEDD8-conjugated Ubc12 (a neddylation E2) but not the amount of ubiquitin-conjugated UbcH7 (a ubiquitination E2 (ref. (Fig. 1f) . Removal of the metazoanspecific WHEP domain from GlyRS (∆WHEP) did not substantially affect the activity of GlyRS, whereas the anticodon-binding domain (ABD) alone had no activity (Fig. 1f) , thus further indicating the involvement of the catalytic domain. In addition, knockdown of GlyRS expression in HeLa cells led to a substantial decrease in NEDD8-conjugated Ubc12 (Ubc12 N8 ) (Fig. 1g) but not ubiquitinated UbcH7 and SUMOylated Ubc9 (Fig. 1h,i) .
We obtained a similar result in HEK293 cells (data not shown). Knockdown of a different tRNA synthetase (SerRS) had no effect on all of the E2s tested ( Fig. 1g-i) . Moreover, knockdown of GlyRS, but not SerRS, also substantially decreased the global level of neddylation, including neddylation of cullin proteins (Fig. 1g) . We observed that GlyRS knockdown had no effect on E1 neddylation (forming UBA3 N8 ) or the level of free NEDD8 (Fig. 1g) . Additionally, GlyRS knockdown did not affect Ube2F ( Supplementary Fig. 2a ), the other neddylation E2 that is evolutionarily more recent and is less prevalent than Ubc12 (ref. 8). These results suggest that GlyRS is required for neddylation and that GlyRS probably functions through promoting or preserving Ubc12 N8 .
GlyRS preferentially binds and protects Ubc12 N8
Ubc12 exists in two forms in the cell: the free form and the conjugated form Ubc12 N8 , which is generated by transfer of a NEDD8 molecule from E1 to the catalytic cysteine (Cys111) of Ubc12 (E2) via a thioester bond 15 . Importantly, once NEDD8 is transferred from E1 to E2, E2 N8 is released from E1 (ref. 16) . We speculate that GlyRS may increase the cellular level of Ubc12 N8 by facilitating the formation of Ubc12 N8 or by protecting Ubc12 N8 after it is released from E1. Two separate in vitro NEDD8 conjugation assays using either radioactive or fluorescence-labeled NEDD8 consistently indicated that GlyRS did not affect the production of Ubc12 N8 ( Supplementary Fig. 3a,b) .
In contrast, we found that GlyRS substantially enhanced the stability of Ubc12 N8 in vitro ( Supplementary Fig. 4) ; this result may explain the activity of GlyRS in increasing the cellular levels of Ubc12 N8 . We hypothesized that the protection might arise from a strong interaction between GlyRS and Ubc12 N8 . We first investigated whether GlyRS, in addition to interacting with NEDD8, might also interact with Ubc12. Interestingly, both glutathione S-transferase (GST) pulldown and HDX analysis confirmed that GlyRS indeed binds Ubc12 and that the catalytic domain of GlyRS is primarily responsible for the interaction (Supplementary Fig. 3c,d ). To quantify the binding, we used biolayer interferometry and immobilized GlyRS on a sensor chip to measure its interaction with Ubc12, NEDD8, and Ubc12 N8 . Remarkably, GlyRS bound to Ubc12 N8 with a K d of 4.09 ± 0.30 nM, which is 100-fold and 30-fold stronger than its binding to Ubc12 alone (K d = 488 ± 73 nM) and to NEDD8 alone (K d = 126 ± 19 nM), respectively (Fig. 2a) . We also analyzed the GlyRS-Ubc12 N8 interaction in (Fig. 2b) . In agreement with the lack of effect of GlyRS knockdown on the cellular level of Ube2F N8 ( Supplementary  Fig. 2a) , the interaction, if any, between GlyRS and Ube2F was much weaker than that between GlyRS and Ubc12 (Supplementary Fig. 2b) . We also performed a coimmunoprecipitation experiment with HEK293 cells. Substantially more input-normalized Ubc12 N8 than free Ubc12 coimmunoprecipitated with GlyRS (Fig. 2c) , thus confirming that GlyRS strongly binds to NEDD8-conjugated Ubc12 in the cell.
Using the crystal structures of human GlyRS 17 and Ubc12 N8 (adapted from its complex with substrate cullin and E3) 18 , we generated a model for the GlyRS-Ubc12 N8 interaction, by using the Patchdock algorithm (http://bioinfo3d.cs.tau.ac.il/PatchDock/) 19, 20 . The top result indicated Ubc12 N8 binding to the catalytic domain of GlyRS, with NEDD8 nestled in between two β-hairpin loops (F84-L93 and I232-M238) (Fig. 2d) . This model is generally consistent with the HDX analysis results ( Supplementary Fig. 1a and Fig. 3d) . To validate the model, we created two deletion mutants of the β-hairpin loops (∆84-93 and ∆232-238) and found that the ∆84-93 mutant showed nine-fold-decreased binding of GlyRS to Ubc12 N8 (K d = 27.0 ± 0.40 nM), and the ∆232-238 mutant showed abolished binding (Fig. 2e,f) . In contrast, deletion of an insertion domain unique to GlyRS (insertion 1) 21 , which showed no involvement in the GlyRS-Ubc12 N8 interaction according to the model (Fig. 2d) , had no effect on the binding (K d = 4.32 ± 0.12 nM) (Fig. 2g) . In accord with its loss of binding to Ubc12 N8 , the ∆232-238 GlyRS was inactive in protecting Ubc12 N8 from degradation in vitro (Supplementary Fig. 4a) and in promoting the level of Ubc12 N8 in HEK293 cells (Fig. 2h) . N8 Interestingly, we found that GlyRS also bound the heterodimeric neddylation E1 enzyme APPBP1-UBA3 ( Fig. 3a and Supplementary  Fig. 5a ). However, unlike NEDD8 and Ubc12, E1 bound the ABD domain of GlyRS, as revealed by both biolayer interferometry analysis and GST pulldowns ( Fig. 3a and Supplementary Fig. 5a ). Furthermore, the APPBP1-UBA3 heterodimer and the APPBP1 subunit alone had similar binding affinity for ABD (Fig. 3b) , thus suggesting that the APPBP1 subunit of E1 is responsible for the GlyRS interaction. We further validated the APPBP1-GlyRS interaction by coimmunoprecipitation in HEK293 cells (Fig. 3c) . A modeling study with Patchdock placed ABD in a position suitable for interacting with the APPBP1 subunit of the E1 (Supplementary Fig. 5b) .
GlyRS binds E1 and facilitates capture of Ubc12
The observation that GlyRS uses different domains to interact with E1 and Ubc12 N8 suggested that GlyRS might be able to bind E1 and Ubc12 N8 simultaneously. As mentioned above, once NEDD8 is transferred from E1 to Ubc12, the interaction between them is weakened, thus releasing Ubc12 N8 from the catalytic subunit UBA3 of E1. Perhaps, by binding the APPBP1 subunit of E1 through the ABD domain, GlyRS is positioned in proximity to capture the released Ubc12 N8 and to provide protection (Fig. 3d) .
We designed an experiment to test this concept. We immobilized E1 to detect its interaction with Ubc12 N8 and GlyRS, both separately and simultaneously. As expected, the binding of Ubc12 N8 to E1 was weak, and the disassociation was fast (Fig. 3e) . In contrast, the binding of GlyRS to E1 was strong (Fig. 3e) . Interestingly, when both Ubc12 N8 and GlyRS were present, the overall binding was stronger than the sum of the individual bindings (Fig. 3e) ; this result suggests that a 
both to immobilized E1 (GST-APPBP1-UBA3). (f) Biolayer interferometry analysis detecting binding of ABD GlyRS (5 µg/mL),
Ubc12 N8 (5 µg/mL), or both to immobilized E1 (GST-APPBP1-UBA3). Black dotted lines indicate the sum of the binding curves for Ubc12 N8 and for full-length GlyRS (e) or for ABD GlyRS (f) to E1. npg a r t i c l e s ternary complex of E1-GlyRS-Ubc12 N8 was formed, thus preventing Ubc12 N8 from being released to the solvent. The ABD of GlyRS was used as a control for this experiment. Although the ABD domain alone interacted with the E1 as strongly as did the full length GlyRS (Fig. 3a,b) , the absence of the catalytic domain of GlyRS for capturing Ubc12 N8 did not permit the formation of a ternary complex. Indeed, we did not detect a synergistic effect between ABD and Ubc12 N8 in binding to E1 (Fig. 3f) .
GlyRS does not interfere with NEDD8 downstream transfer
Because we observed tight binding between GlyRS and Ubc12 N8 , it was important to confirm that the binding did not impede Ubc12 N8 from passing NEDD8 to downstream targets such as cullin1. Notably, the protection of Ubc12 N8 by GlyRS did not appear to require burying of the thioester linkage. In our model of the GlyRS-Ubc12 N8 complex, the thioester bond between the C-terminal glycine residue Gly76 of NEDD8 and Cys111 of Ubc12 faces outward rather than being buried inside (Fig. 2d) and is fully accessible to the acceptor residue Lys720 of cullin1 (Supplementary Fig. 6a ). We tested whether the E3-substrate pair of RING-box protein 1 (Rbx1)-cullin1 could bind to Ubc12 N8 in the presence of GlyRS. Rbx1-cullin1 indeed bound Ubc12 N8 in the presence of GlyRS, and moreover the binding appeared to release GlyRS from Ubc12 N8 (Supplementary Fig. 6b ), presumably allowing GlyRS to turn over. Using an in vitro neddylation assay, we further demonstrated that the presence of wild-type (WT) GlyRS, but not ∆232-238 GlyRS, which lacks Ubc12 N8 binding (Fig. 2e) , increased the neddylation of cullin1, presumably by protecting Ubc12 N8 (Supplementary Fig. 6c ).
GlyRS regulates cell-cycle progression
Cullin neddylation activates the cullin-RING ubiquitin ligases and facilitates the degradation of their downstream targets, including the cell-cycle inhibitor p27 (ref. 22 and Fig. 4a ). p27 induces cell-cycle arrest by binding to cyclin-CDK complexes and inhibiting their catalytic activity 23 . Therefore, degradation of p27 through cullin neddylation promotes cell-cycle progression and cell proliferation. Because this is a well-established pathway, we focused on p27 degradation and cell-cycle progression to study the biological role of GlyRS in neddylation.
To evaluate p27 degradation in cells, we used cycloheximide (CHX), an inhibitor of translation, to block new protein synthesis. The level of p27 decreased rapidly after CHX treatment in untreated HeLa cells or cells transfected with empty vectors or plasmids expressing short hairpin RNAs (shRNAs) against SerRS (shSerRS) (Fig. 4b). (We included the proteasome inhibitor MG132 to confirm the ubiquitin-dependent proteolysis of p27.) However, treatment with shRNAs against GlyRS (shGlyRS) enhanced the stability of p27 (Fig. 4b) , as evidenced by both the increased level of p27 before the CHX treatment and the extended half-life of p27 during the treatment. Moreover, the stabilization effect on p27 was concurrent with a decreased level of cullin N8 (Fig. 4b) . To further confirm that this effect was related to neddylation, we used the neddylation-specific inhibitor MLN4924 (ref. 24) as the positive control. Indeed, MLN4924 treatment abolished cullin neddylation and blocked p27 degradation (Fig. 4a,b) . Abnormal accumulation of p27 leads to cell-cycle arrest 25 . Hence, compared with the control cells, cells transfected with shGlyRS or treated with MLN4924 showed a substantial decrease in the number of diploid (2n) cells and an increase in the number of tetraploid (4n) cells (Fig. 4c) , thus indicating cellcycle arrest.
Active site is not essential for GlyRS-mediated neddylation
Although our study was initially inspired by the chemical similarity between reactions catalyzed by GlyRS and E1, we have not been able to detect an E1-like activity of GlyRS toward NEDD8 (data not shown). Moreover, we found that removal of the C-terminal diglycine motif of NEDD8 had little effect on the GlyRS-NEDD8 interaction (Supplementary Fig. 1b,c) . To further clarify whether the active site and the ability to synthesize Gly-AMP are important in GlyRSmediated neddylation, we tested the GlyRS mutant G526R. The G-to-R substitution blocks the ATP-binding site of GlyRS (Fig. 5a) and completely abolishes the aminoacylation activity 17 . However, despite having reduced activity, G526R GlyRS was active in increasing the cellular level of Ubc12 N8 (Fig. 5b) npg a r t i c l e s and cell-cycle progression in the presence of a low dose of the neddylation inhibitor MLN4924 (Fig. 5c,d ), thus suggesting that the active site or the ability to synthesize Gly-AMP may affect, but is not essential for, the role of GlyRS in neddylation. Interestingly, we found that G526R GlyRS had decreased (approximately ten-fold) binding to Ubc12 N8 (K d = 39.5 ± 1.2 nM) compared with that of WT GlyRS (Fig. 5e) ; this result may explain the reduced activity of G526R GlyRS in increasing the cellular level of Ubc12 N8 and in facilitating neddylation.
DISCUSSION
Human GlyRS contains a metazoan-specific WHEP domain, a catalytic domain and an ABD (Fig. 1d) . Only the catalytic domain and ABD are essential for tRNA aminoacylation 17 , and interestingly both are involved in promoting neddylation. Our results from biochemical and structural analysis support a model in which GlyRS, by docking on the APPBP1 subunit of E1 through the ABD domain, is sufficiently close to capture the NEDD8-conjugated E2 (Ubc12 N8 ), via the catalytic domain, after Ubc12 N8 is released from the E1 and before it finds the correct E3 and substrate and transfers the NEDD8 modifier. The confinement provided by the synthetase would protect the conjugated E2 from random hydrolysis and thereby enhance the overall efficiency of neddylation. It is possible that the protection of GlyRS is essential for neddylation. However, the evaluation of this possibility is complicated because GlyRS is also essential for protein synthesis, and the same domains of GlyRS are used in both activities. Neddylation activates cullin proteins as molecular scaffolds in the assembly of the cullin-RING-box protein E3 ubiquitin ligase, the largest family of ubiquitination E3 ligases. In humans, one of the six cullins (cullins 1, 2, 3, 4A, 4B, and 5) assembles with one of the two RING-box proteins (Rbx1 and Rbx2) and subsequently mediates the ubiquitination and degradation of thousands of targets, thereby regulating a vast array of biological functions 26, 27 . In the hierarchical cascade of cullin neddylation, selectivity is achieved through the collaboration of RING and E2. Two E2s for NEDD8, the same number as the number of RINGs, have been identified: Ubc12 specifically pairs with Rbx1 and mediates neddylation of cullin1-4, and Ube2F pairs with Rbx2 and controls cullin5 neddylation 8, 28 . Interestingly, Ube2F-Rbx2-cullin5 neddylation constitutes a metazoan-specific NEDD8 cascade 8 , whereas Ubc12, Rbx1, and cullin1, along with NEDD8 and E1, are present in all eukaryotes. Although GlyRS is ubiquitously and abundantly present in all organisms, eukaryotic GlyRSs are substantially different from most of their bacterial counterparts 29 . Our observation that GlyRS specifically binds Ubc12 but not Ube2F (Supplementary Fig. 2b) suggests that GlyRS is a component of the prototypic cascade of neddylation and that the role of GlyRS in protecting the conjugated Ubc12 and facilitating neddylation may have existed ever since the modification first occurred. Further observations that GlyRS interacts with multiple components of the prototypic neddylation pathway and that the metazoan-specific WHEP domain is dispensable in all these interactions (Fig. 1e, Supplementary Fig. 3c and Supplementary  Fig. 5a ) are consistent with this concept.
Apparently, dysregulation of neddylation can cause abnormalities in protein degradation through the ubiquitin-proteasome system and can play a pathological role in various diseases. It has been reported that high levels of NEDD8 are present in ubiquitinated inclusion bodies in neural tissues collected from patients with neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis 30, 31 . Interestingly, dominant mutations in GlyRS have been found to cause a neurodegenerative disorder called Charcot-Marie-Tooth disease type 2D (CMT2D) in patients 32, 33 . In fact, the G526R mutation that we tested is a CMT2D-causing mutation 34 . Although G526R GlyRS, compared with the WT protein, exhibits less binding to Ubc12 N8 (Fig. 5e) , genetic studies in mouse Figure 5 The active site is not essential to the role of GlyRS in neddylation. (a) Crystal structure of the active site of human GlyRS bound with glycyl-sulfamoyladenosine (Gly-SA) (PDB 2ZT8) and of human G526R GlyRS (PDB 2PMF npg a r t i c l e s facilitates neddylation, including neddylation of cullin proteins of the ubiquitin-proteasome system (Fig. 6b) . Through its dual functions, GlyRS supports both general protein production and selective protein degradation, and hence it may play a crucial role in maintaining the homeostasis of the eukaryotic proteome.
METHODS
Methods and any associated references are available in the online version of the paper. 
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Reprints and permissions information is available online at http://www.nature.com/ reprints/index.html. models have clearly demonstrated that CMT2D is caused by a toxic gain-of-function mechanism rather than the loss of function of either canonical or noncanonical activities of GlyRS 35 . Moreover, an aberrant interaction between neuropilin 1 and mutant, but not WT, GlyRS has recently been found to account (at least partially) for the selective motor-neuron pathology in CMT2D 36 . Finally, no pathological aggregation or ubiquitin-positive inclusion has been detected in neural tissues from CMT2D mouse models 37 , thus further indicating that dysregulation of neddylation is unlikely to be involved in the etiology of CMT2D. Upregulation of neddylation is strongly associated with cancer 9,38,39 . Many targets of neddylation are involved in regulating cancer progression, including regulators of the cell cycle (p27 (ref. 40) and cyclin E 41 -1 (ref. 45) ). In fact, the neddylation pathway has been recognized as an important anticancer target, and the selective NEDD8 E1 inhibitor MLN4924 is currently being tested in several clinical trials as a treatment for hematological malignancies and solid tumors 46, 47 . As a component of the translation machinery, GlyRS is expected to be associated with cancer progression, which requires robust protein-synthesis activity. However, the critical role of GlyRS in neddylation revealed in this study suggests that GlyRS might be associated with cancer for an additional reason. Notably, in an examination of the expression of aminoacyl-tRNA synthetase in previously generated microarray data sets from 3,557 breast cancer patients 48 , we found that GlyRS showed the strongest association with cancer mortality among all 20 aminoacyl-tRNA synthetases (Fig. 6a) . Following GlyRS at the top of the list were ThrRS and LysRS (Fig. 6a) . Notably, ThrRS has been reported to be an angiogenic, promigratory extracellular signaling molecule 49 , and LysRS has been found to promote cancer cell migration and metastasis by inhibiting ubiquitindependent degradation of the laminin receptor 50, 51 .
In conclusion, by using biochemical, structural, and cell-based approaches, we found that GlyRS, in addition to being an essential enzyme in protein synthesis, also acts as a chaperone that critically Figure 6 Dual function of GlyRS in protein synthesis and neddylation. (a) Kaplan-Meier plots and hazard ratio (HR) analysis of human tRNA synthetases in breast cancer. Patient samples were divided in halves as lowexpression (black) and high-expression (red) sets for each tRNA synthetase in the analysis. n = 3,557 patients. P values were calculated with two-sided log-rank tests. (b) Schematic summarizing the dual function of GlyRS in aminoacylation as an enzyme and in neddylation as a chaperone that supports protein synthesis and cell-cycle progression.
